Citadel Advisors’s Houghton Mifflin Harcourt Company HMHC Stock Holding History

Citadel Advisors’s Portfolio HMHC Stock Details HMHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-43,000	Closed	-$903K	–	14892
2022 Q1	$903K	Sell	43,000 -54,300	-56%	-$1.02M	﹤0.01%	7947
2021 Q4	$1.57M	Buy	97,300 +46,000	+90%	+$699K	﹤0.01%	6791
2021 Q3	$689K	Sell	51,300 -46,900	-48%	-$590K	﹤0.01%	9116
2021 Q2	$1.08M	Buy	98,200 +28,600	+41%	+$269K	﹤0.01%	8167
2021 Q1	$530K	Buy	69,600 +37,000	+113%	+$211K	﹤0.01%	9557
2020 Q4	$109K	Buy	32,600 +6,500	+25%	+$19.4K	﹤0.01%	10174
2020 Q3	$45K	Buy	26,100 +5,100	+24%	+$11.4K	﹤0.01%	9644
2020 Q2	$38K	Buy	+21,000	New	+$33.7K	﹤0.01%	9409

Other funds holding HMHC

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Citadel Advisors's HMHC Position: Q2 2022 in Review

Citadel Advisors sold out of Houghton Mifflin Harcourt Company (HMHC) in Q2 2022, closing a stake of 128,483 shares — an estimated $2.7M sold.

Citadel Advisors first reported a position in HMHC in Q4 2013 and held it in 30 quarters. The position peaked at $8.3M in Q3 2015. 1 fund tracked by Wall St. Rank holds HMHC as of Q2 2022.

Citadel Advisors reported no remaining Houghton Mifflin Harcourt Company position as of Q2 2022 after selling out during the quarter.
Citadel Advisors sold 128,483 Houghton Mifflin Harcourt Company shares in Q2 2022, an estimated $2.7M.
Citadel Advisors first reported a position in Houghton Mifflin Harcourt Company in Q4 2013 and held it in 30 quarters.
Citadel Advisors's Houghton Mifflin Harcourt Company position peaked at $8.3M in Q3 2015.
1 fund tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.